JNBA Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

JNBA Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24	Closed	-$2K	–	680
2021 Q1	$2K	Hold	24	–	–	﹤0.01%	586
2020 Q4	$2K	Hold	24	–	–	﹤0.01%	544
2020 Q3	$2K	Hold	24	–	–	﹤0.01%	509
2020 Q2	$1K	Hold	24	–	–	﹤0.01%	531
2020 Q1	$1K	Hold	24	–	–	﹤0.01%	525
2019 Q4	$1K	Hold	24	–	–	﹤0.01%	579
2019 Q3	$1K	Hold	24	–	–	﹤0.01%	566
2019 Q2	$1K	Hold	24	–	–	﹤0.01%	627
2019 Q1	$1K	Hold	24	–	–	﹤0.01%	526
2018 Q4	$1K	Buy	+24	New	+$676	﹤0.01%	501
2018 Q3	–	Sell	-24	Closed	-$1K	–	490
2018 Q2	$1K	Hold	24	–	–	﹤0.01%	505
2018 Q1	$1K	Hold	24	–	–	﹤0.01%	475
2017 Q4	$1K	Hold	24	–	–	﹤0.01%	462
2017 Q3	$1K	Buy	+24	New	+$565	﹤0.01%	453

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SDH

Sloy Dahl & Holst Vancouver, Washington $811M AUM 19.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

JNBA Financial Advisors's ARKG Position: Q2 2021 in Review

JNBA Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 24 shares — an estimated $2K sold.

JNBA Financial Advisors first reported a position in ARKG in Q3 2017 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

JNBA Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
JNBA Financial Advisors sold 24 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $2K.
JNBA Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2017 and held it in 14 quarters.
JNBA Financial Advisors's ARK Genomic Revolution ETF position peaked at $2K in Q1 2021.
514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on JNBA Financial Advisors's 13F filing for Q2 2021, filed 4 Aug 2021.